Interesting that V-Wave have just recently been awarded CE Mark for their heart failure device...
https://www.medgadget.com/2020/03/v-wave-shunt-for-relief-of-heart-failure-symptoms-cleared-in-eu.html
from a study that actually concluded in late 2017....
https://clinicaltrials.gov/ct2/show/NCT01965015?term=V-wave&cond=Heart+Failure&draw=1&rank=2
Note the small number of participants (16) and note in the first article of the of the recent increase in all parameters (participants 500, randomised, double blind trial) in an attempt to achieve FDA approval.
Equally CE mark was recently awarded to Keystone Heart for their Triguard Cerebral embolic protection device....
https://www.cathlabdigest.com/content/triguard-3-cerebral-embolic-protection-device-receives-ce-mark-use-transcatheter-heart-procedures
on a study completed mid 2019...
https://clinicaltrials.gov/ct2/show/NCT02536196?term=Triguard&cond=Cerebral+embolic+protection&draw=2&rank=1
So point being Oncosil’s study is still ongoing....
https://clinicaltrials.gov/ct2/show/NCT03003078?term=Oncosil&cond=Pancreas+Cancer&draw=2&rank=2
....”estimated completion date June 2020”...
The question is realistically can they be awarded marking for a study yet to be completed?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.070(5.69%) |
Mkt cap ! $16.49M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.11 | $72.36K | 60.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9286 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 412 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |